Quality control of right heart catheterization for pulmonary vascular diseases in China
China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-A Quality Control on Right Heart Catheterization
China-Japan Friendship Hospital · NCT06954727
This study looks at the quality of right heart catheterization procedures for people with suspected pulmonary hypertension in China to see how well they are being done and what outcomes patients experience.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 14 Years and up |
| Sex | All |
| Sponsor | China-Japan Friendship Hospital (other) |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06954727 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the quality control of right heart catheterization (RHC) across multiple pulmonary hypertension centers in China. It aims to collect and analyze data from patients aged 14 and older who undergo RHC due to dyspnea or suspected pulmonary hypertension. The study will gather both retrospective and prospective data, including hemodynamic parameters, diagnostic classifications, and treatment plans, while ensuring routine follow-up for participants. The data will be managed through an Electronic Data Capture system to facilitate quality control and statistical analysis.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 14 years or older who are undergoing right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension.
Not a fit: Patients who have missing vital data or who do not consent to follow-up will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and management of pulmonary vascular diseases in China, leading to improved patient outcomes.
How similar studies have performed: While this study addresses a critical gap in the implementation of right heart catheterization in China, similar studies have shown success in other regions, indicating the potential for positive outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension * Age ≥14 years old Exclusion Criteria: * Vital data missing * Did not sign informed consent or did not agree to follow-up
Where this trial is running
Beijing
- China-Japan Friendship Hospital — Beijing, China (RECRUITING)
Study contacts
- Principal investigator: Zhenguo Zhai, PhD — China-Japan Friendship Hospital
- Study coordinator: Zhenguo Zhai
- Email: zhaizhenguo2011@126.com
- Phone: 010-8420-6265
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Hypertension, Pulmonary Embolism, Pulmonary Arterial Hypertension, Right Heart Catheterization, right heart catheterization, pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular disease